These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12106791)

  • 41. Leishmania infantum promastigotes reduce entry of HIV-1 into macrophages through a lipophosphoglycan-mediated disruption of lipid rafts.
    Garg R; Lodge R; Descoteaux A; Tremblay MJ
    J Infect Dis; 2008 Jun; 197(12):1701-8. PubMed ID: 18422456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Macrophage Mitochondrial Biogenesis and Metabolic Reprogramming Induced by Leishmania donovani Require Lipophosphoglycan and Type I Interferon Signaling.
    Acevedo Ospina H; Guay-Vincent MM; Descoteaux A
    mBio; 2022 Dec; 13(6):e0257822. PubMed ID: 36222510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan.
    Desjardins M; Descoteaux A
    J Exp Med; 1997 Jun; 185(12):2061-8. PubMed ID: 9182677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specific recognition and cleavage of galectin-3 by Leishmania major through species-specific polygalactose epitope.
    Pelletier I; Sato S
    J Biol Chem; 2002 May; 277(20):17663-70. PubMed ID: 11882664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophages.
    Descoteaux A; Turco SJ; Sacks DL; Matlashewski G
    J Immunol; 1991 Apr; 146(8):2747-53. PubMed ID: 1707920
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Leishmania donovani activates SREBP2 to modulate macrophage membrane cholesterol and mitochondrial oxidants for establishment of infection.
    Mukherjee M; Basu Ball W; Das PK
    Int J Biochem Cell Biol; 2014 Oct; 55():196-208. PubMed ID: 25218172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan.
    Descoteaux A; Matlashewski G; Turco SJ
    J Immunol; 1992 Nov; 149(9):3008-15. PubMed ID: 1383336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Wnt5a Signaling Promotes Host Defense against
    Chakraborty A; Kurati SP; Mahata SK; Sundar S; Roy S; Sen M
    J Immunol; 2017 Aug; 199(3):992-1002. PubMed ID: 28659356
    [No Abstract]   [Full Text] [Related]  

  • 49. Structure of the phosphosaccharide-inositol core of the Leishmania donovani lipophosphoglycan.
    Turco SJ; Orlandi PA; Homans SW; Ferguson MA; Dwek RA; Rademacher TW
    J Biol Chem; 1989 Apr; 264(12):6711-5. PubMed ID: 2708338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins.
    Russo DM; Turco SJ; Burns JM; Reed SG
    J Immunol; 1992 Jan; 148(1):202-7. PubMed ID: 1370169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Leishmania-induced biphasic ceramide generation in macrophages is crucial for uptake and survival of the parasite.
    Majumder S; Dey R; Bhattacharjee S; Rub A; Gupta G; Bhattacharyya Majumdar S; Saha B; Majumdar S
    J Infect Dis; 2012 May; 205(10):1607-16. PubMed ID: 22517914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of Leishmania donovani variant clones using anti-lipophosphoglycan monoclonal antibodies.
    McNeely TB; Tolson DL; Pearson TW; Turco SJ
    Glycobiology; 1990 Sep; 1(1):63-9. PubMed ID: 2136382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis.
    Moore KJ; Matlashewski G
    J Immunol; 1994 Mar; 152(6):2930-7. PubMed ID: 8144893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure of Leishmania mexicana lipophosphoglycan.
    Ilg T; Etges R; Overath P; McConville MJ; Thomas-Oates J; Thomas J; Homans SW; Ferguson MA
    J Biol Chem; 1992 Apr; 267(10):6834-40. PubMed ID: 1551890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The major concanavalin A-binding surface glycoprotein of Leishmania donovani chagasi promastigotes is involved in attachment to human macrophages.
    Wilson ME; Hardin KK
    J Immunol; 1988 Jul; 141(1):265-72. PubMed ID: 3379307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biosynthesis of lipophosphoglycan from Leishmania major: solubilization and characterization of a (beta 1-3)-galactosyltransferase.
    Ng K; Handman E; Bacic A
    Biochem J; 1996 Jul; 317 ( Pt 1)(Pt 1):247-55. PubMed ID: 8694771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. C-reactive protein-mediated phagocytosis of Leishmania donovani promastigotes does not alter parasite survival or macrophage responses.
    Bodman-Smith KB; Mbuchi M; Culley FJ; Bates PA; Raynes JG
    Parasite Immunol; 2002; 24(9-10):447-54. PubMed ID: 12654086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired recruitment of the small GTPase rab7 correlates with the inhibition of phagosome maturation by Leishmania donovani promastigotes.
    Scianimanico S; Desrosiers M; Dermine JF; Méresse S; Descoteaux A; Desjardins M
    Cell Microbiol; 1999 Jul; 1(1):19-32. PubMed ID: 11207538
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Leishmania donovani exploits host deubiquitinating enzyme A20, a negative regulator of TLR signaling, to subvert host immune response.
    Srivastav S; Kar S; Chande AG; Mukhopadhyaya R; Das PK
    J Immunol; 2012 Jul; 189(2):924-34. PubMed ID: 22685311
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leishmania invasion and phagosome biogenesis.
    Lodge R; Descoteaux A
    Subcell Biochem; 2008; 47():174-81. PubMed ID: 18512351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.